FGAM
AMAG

Financial Gravity Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Financial Gravity Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-463
Closed -$9K – 1685
2018
Q1 		$9K Buy
+463
New +$7.83K 0.01% 611

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Gravity Asset Management's AMAG Position: Q2 2018 in Review

Financial Gravity Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2018, closing a stake of 463 shares — an estimated $9K sold.

Financial Gravity Asset Management first reported a position in AMAG in Q1 2018 and held it in 1 quarter. The position peaked at $9K in Q1 2018. 173 funds tracked by Wall St. Rank hold AMAG as of Q2 2018.

  • Financial Gravity Asset Management reported no remaining AMAG Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Financial Gravity Asset Management sold 463 AMAG Pharmaceuticals shares in Q2 2018, an estimated $9K.
  • Financial Gravity Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Financial Gravity Asset Management's AMAG Pharmaceuticals position peaked at $9K in Q1 2018.
  • 173 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2018.

Based on Financial Gravity Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.